ARCHIVES

DCT Advisors Approve Recompetition Of Drug Discovery Groups

This article is from The Cancer Letter archive.

Vol. 21 No. 25 | June 23, 1995

Download PDF Visit The Full Archive

Related Articles

Aggressive Cancer Screening Increases Overdiagnosis, JAMA Paper Argues

October 30, 2009

Obituaries: Karen Johnson of NCI; Merrill Egorin of UPCI

September 17, 2010

Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting

June 25, 2010

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977

Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results

April 4, 1986

In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent

November 27, 1987